← Back to Search

Behavioral Intervention

El Faro Treatment for ADHD

N/A
Waitlist Available
Led By John Mitchell, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will help Latinx families of children with ADHD understand & cope with the disorder. El Futuro & Duke will collaborate to pilot-test an adapted El Faro treatment.

Who is the study for?
This trial is for Latinx children aged 6-12 with ADHD, who are generally healthy and not on changing psychiatric meds. Their caregivers must be over 18. It's designed to help families cope with ADHD-related challenges.
What is being tested?
The El Faro treatment intervention is being tested, which aims to support Latinx families in managing ADHD stress. The study will pilot-test this approach through a partnership between El Futuro and the Duke ADHD Program.
What are the potential side effects?
Since El Faro is a psychosocial intervention rather than a medication, it may not have typical medical side effects but could include emotional discomfort or increased family tension during therapy sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of adapted El Faro Treatment as measured by caregiver perceptions
Acceptability of adapted El Faro Treatment as measured by how satisfactory participants felt that the treatment was overall
Feasibility of adapted El Faro Treatment as measured by percentage of attrition
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment ParticipantsExperimental Treatment1 Intervention
Active treatment group participants
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
El Faro Treatment Intervention
2023
N/A
~40

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,463 Previous Clinical Trials
2,981,515 Total Patients Enrolled
3 Trials studying Mental Health
272 Patients Enrolled for Mental Health
John Mitchell, PhDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
92 Total Patients Enrolled
~15 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top